Beam Therapeutics to Participate in Upcoming May Investor Conferences
CAMBRIDGE, Mass., May 17, 2023 -- Beam Therapeutics Inc. , a biotechnology company developing precision genetic medicines through base editing, today announced that management plans to participate... | May 17, 2023
United Kingdom Dan Budwick Chelcie Lister Strategic Communications Beam Therapeutics Inc Virtual Gene Editing
Source: marketscreener.com